Clinical Trials Browser

Not yet recruiting × Tuberous Sclerosis × 1 year × Clear all

Fabry Disease, Lupus Erythematosus, Systemic, Nephritis, Hereditary, Periodontal Diseases, Periodontitis, Tuberous Sclerosis, Renal Insufficiency, Chronic

NCT07287202 2025-12-23

Safety, Tolerability, and Pharmacokinetics of SVG103 (Paxalisib) in Focal Cortical Dysplasia Type II (FCD-II), Tuberous Sclerosis Complex (TSC) or Hemimegalencephaly (HME)

Phase 1/2 Not yet recruiting

15 enrolled

Focal Cortical Dysplasia, Tuberous Sclerosis, Hemimegalencephaly

Clinical Trials

PERIO-RA-RE

Safety, Tolerability, and Pharmacokinetics of SVG103 (Paxalisib) in Focal Cortical Dysplasia Type II (FCD-II), Tuberous Sclerosis Complex (TSC) or Hemimegalencephaly (HME)